This invention relates to piperazine derivatives of the formula:
##STR1##
wherein each symbol is as defined in the description, and its pharmaceutically
acceptable salt, to processes for preparation thereof, to pharmaceutical composition
comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated
diseases in human being or animals.